SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001811764-22-000051
Filing Date
2022-05-13
Accepted
2022-05-13 08:18:31
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B3 a424b3and10-qcombined.htm 424B3 500013
2 EX-31.1 exhibit311-10qx03312022.htm EX-31.1 11439
3 EX-31.2 exhibit312-10qx03312022.htm EX-31.2 12182
4 EX-32 exhibit32-10qx03312022.htm EX-32 8935
5 point-logoxcolour1a.jpg GRAPHIC 17537
  Complete submission text file 0001811764-22-000051.txt   557881
Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (317) 543-9957
POINT Biopharma Global Inc. (Filer) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-258325 | Film No.: 22920338
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences